Browsing: eli lilly alzheimers medication

Eli Lilly gains approval for their Alzheimer’s drug donanemab (Kisunla) in Japan, offering another treatment targeting amyloid plaques like Eisai’s Leqembi as the ageing population drives a rise in dementia cases.

Eli Lilly’s Alzheimer’s medication donanemab shows significant potential in slowing cognitive decline. Find out more